Literature DB >> 7792040

Renal involvement in the hypereosinophilic syndrome.

J L Motellón1, C Bernis, A García-Sánchez, E Gruss, J A Traver.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7792040

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome.

Authors:  Jian-Hua Dong; Shu-Tian Xu; Feng Xu; Yu-Chao Zhou; Ze Li; Shi-Jun Li
Journal:  Clin Exp Nephrol       Date:  2021-01-04       Impact factor: 2.801

2.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

3.  Renal involvement in idiopathic hypereosinophic syndrome.

Authors:  Nathalie Shehwaro; Anne Lyse Langlois; Victor Gueutin; Hassane Izzedine
Journal:  Clin Kidney J       Date:  2013-06

Review 4.  Acute kidney injury secondary to thrombotic microangiopathy associated with idiopathic hypereosinophilic syndrome: a case report and review of the literature.

Authors:  Diana Curras-Martin; Swapnil Patel; Huzaif Qaisar; Sushil K Mehandru; Avais Masud; Mohammad A Hossain; Gurpreet S Lamba; Harry Dounis; Michael Levitt; Arif Asif
Journal:  J Med Case Rep       Date:  2019-09-05

5.  Renal thrombotic microangiopathy and FIP1L1/PDGFRα-associated myeloproliferative variant of hypereosinophilic syndrome.

Authors:  Anne Lyse Langlois; Nathalie Shehwaro; Claire Rondet; Youssef Benbrik; Karim Maloum; Victor Gueutin; Philippe Rouvier; Hassane Izzedine
Journal:  Clin Kidney J       Date:  2013-08

6.  Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.

Authors:  Yuto Hayama; Fuminori Tomyo; Masaki Ueno; Shinichiro Asakawa; Shigeyuki Arai; Osamu Yamazaki; Yoshifuru Tamura; Makoto Mochizuki; Ryuji Ohashi; Shigeru Shibata; Yoshihide Fujigaki
Journal:  Intern Med       Date:  2021-06-05       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.